INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form. Use additional sheet(s) if necessary.

1. Company Name and Address4. EPA ProductRegistration

United States Environmental Protection

Agency Washington, D.C. 20460

DATA CALL-IN RESPONSE

3. Date and Type of DCI 

PRODUCT SPECI03-Mar-2008ID # PDCI-09890

2. Case # and Name

3026 Benzisothiazolin-3-oneChemical # and Name 098901

1,2-Benzisothiazolin-3-one

5. I wish to cancel this product registration voluntarily

6. Generic Data 7. Product Specific Data

7a. My product is an MUP andI agree to satisfy the MUP requirements on the attached form entitled "Requirements Status and Registrant's Response."

6a. I am claiming a GenericData Exemption because I obtain the active ingredient from the source EPA registration number listed below.

6b. I agree to satisfy Generic Data requirements as indicated on the attached form entitled "Requirements Status and Registrant's Response."

N.A. N.A.N.A. N.A.N.A. N.A.N.A. N.A.N.A. N.A.N.A. N.A.N.A. N.A.N.A. N.A.N.A. N.A.N.A. N.A.N.A. N.A.N.A. N.A.

10. Name of Company 11. Phone Numb

9. Date 8. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete. I acknowledge that any knowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law.

Signature and Title of Company's Authorized Representative__________________________________
INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form. 

Use additional sheet(s) if necessary.

4. Guideline Requirement Number

5. Study Title

1. Company Name and Address

United States Environmental Protection

Agency Washington, D.C. 20460

REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE

3. Date and Type of DC

ID #PRODUCT SPEC

2. Case # and Name

3026 Benzisothiazolin-3-one

EPA Reg. No.

7. Test Substance

6. Use Pattern

P

R

O

T

O

C

O

L

Progress

Reports

1 2 3

DD-MMM-YYYY

PDCI-09890

NNNNNN-NNNNN

D R A F T C O P Y

Product Chemistry Data Requirements (Antimicrobial)

830.1550 Product Identity and composition (29) EE, K, M, Q, X EP 830.1600 Description of materials used to produce the product (30) EE, K, M, Q, X EP 830.1620 Description of production process (31) EE, K, M, Q, X EP 830.1650 Description of formulation process (32) EE, K, M, Q, X EP 830.1670 Discussion of formation of impurities (33) EE, K, M, Q, X EP & possibly TGA830.1700 Preliminary analysis (34 ,35 ,36) EE, K, M, Q, X EP & possibly TGA830.1750 Certified limits (37) EE, K, M, Q, X EP 830.1800 Enforcement analytical method (38) EE, K, M, Q, X EP 830.6302 Color (15) EE, K, M, Q, X TGAI 830.6303 Physical state (17) EE, K, M, Q, X TGAI & EP 830.6304 Odor (18) EE, K, M, Q, X TGAI 

12. Name of Company 13. Phone NumbSignature and Title of Company's Authorized Representative__________________________________10. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete. I acknowledge that any knowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law

11. Date
INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form. 

Use additional sheet(s) if necessary.

4. Guideline Requirement Number

5. Study Title

1. Company Name and Address

United States Environmental Protection

Agency Washington, D.C. 20460

REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE

3. Date and Type of DC

ID #PRODUCT SPEC

2. Case # and Name

3026 Benzisothiazolin-3-one

EPA Reg. No.

7. Test Substance

6. Use Pattern

P

R

O

T

O

C

O

L

Progress

Reports

1 2 3

DD-MMM-YYYY

PDCI-09890

NNNNNN-NNNNN

D R A F T C O P Y

830.6313 Stability to normal and elevated temperatures, (8 ,9) EE, K, M, Q, X TGAI 

metals, and metal ions

830.6314 Oxidizing or reducing action (10) EE, K, M, Q, X EP 830.6315 Flammability (11) EE, K, M, Q, X EP 830.6316 Explodability (12) EE, K, M, Q, X EP 

830.6317 Storage stability EE, K, M, Q, X EP 

830.6319 Miscibility (14) EE, K, M, Q, X EP 

830.6320 Corrosion characteristics EE, K, M, Q, X EP 

830.6321 Dielectric breakdown voltage (16) EE, K, M, Q, X EP 830.7000 pH (6 ,7) EE, K, M, Q, X TGAI & EP 

830.7050 UV/Visible absorption EE, K, M, Q, X TGAI 

830.7100 Viscosity (13) EE, K, M, Q, X EP 830.7200 Melting point/melting range (19 ,20) EE, K, M, Q, X TGAI or PAI 

Initial to indicate certification as to information on this page (fulltext of certification is on page one).

Date
INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form. 

Use additional sheet(s) if necessary.

4. Guideline Requirement Number

5. Study Title

1. Company Name and Address

United States Environmental Protection

Agency Washington, D.C. 20460

REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE

3. Date and Type of DC

ID #PRODUCT SPEC

2. Case # and Name

3026 Benzisothiazolin-3-one

EPA Reg. No.

7. Test Substance

6. Use Pattern

P

R

O

T

O

C

O

L

Progress

Reports

1 2 3

DD-MMM-YYYY

PDCI-09890

NNNNNN-NNNNN

D R A F T C O P Y

830.7220 Boiling point/boiling range (21 ,22) EE, K, M, Q, X TGAI or PAI 830.7300 Density/relative density (23 ,24) EE, K, M, Q, X TGAI & EP 830.7370 Dissociation constants in water (2 ,3) EE, K, M, Q, X TGAI or PAI 830.7550 Partition coefficient (n-octanol/water), shake flask (4) EE, K, M, Q, X TGAI or PAI 

method

830.7570 Partition coefficient (n-octanol/water), estimation by (5) EE, K, M, Q, X TGAI or PAI 

liquid chromatography

830.7840 Water solubility: Column elution method, shake flask (25) EE, K, M, Q, X TGAI or PAI 

method

830.7860 Water solubility, generator column method (26) EE, K, M, Q, X TGAI or PAI 830.7950 Vapor pressure (27 ,28) EE, K, M, Q, X TGAI or PAI 

Toxicology Data Requirements (Antimicrobial)

870.1100

Acute Oral Toxicity (51 ,52) EE, K, M, Q, X EP; MP; TGAI 

870.1200

Acute dermal toxicity (1 ,39 ,40) EE, K, M, Q, X EP; MP; TGAI 

(47 ,48 ,49,50)

870.1300

Acute inhalation toxicity EE, K, M, Q, X EP; MP; TGAI/EP 

Initial to indicate certification as to information on this page (fulltext of certification is on page one).

Date
INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form. 

Use additional sheet(s) if necessary.

4. Guideline Requirement Number

5. Study Title

1. Company Name and Address

United States Environmental Protection

Agency Washington, D.C. 20460

REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE

3. Date and Type of DC

ID #PRODUCT SPEC

2. Case # and Name

3026 Benzisothiazolin-3-one

EPA Reg. No.

7. Test Substance

6. Use Pattern

P

R

O

T

O

C

O

L

Progress

Reports

1 2 3

DD-MMM-YYYY

PDCI-09890

NNNNNN-NNNNN

D R A F T C O P Y

(41 ,42 ,43,44)

870.2500

Acute dermal irritation EE, K, M, Q, X EP; MP; TGAI/EP

870.2600 Skin sensitization (45 ,46) EE, K, M, Q, X EP; MP; TGAI 

870.2400

Acute eye irritation EE, K, M, Q, X 

Initial to indicate certification as to information on this page (fulltext of certification is on page one).

Date
Case # and Name: 3026 Benzisothiazolin-3-one

DCI Number: PDCI-098901-27549

Footnotes: [The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Key:

United States Environmental Protection

Agency Washington, D.C. 20460

FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTS

TGAI & EP = Technical Grade of the Active Ingredient and End-Use Product; EP; MP; TGAI = End Use Product; Manufacturing Use Product; Technical Grade Technical Grade of the Active Ingredient or Pure Active Ingredient; EP = End Use Product [EP]; TGAI = Technical Grade Active Ingredient [TGAI]; EP; TGAI = Active Ingredient; EP & possibly TGAI = End- Use Product and possibly Technical Grade Active Ingredient

Use Categories Key:

K - M - Q - 

ResidentialIndoor nonfood useResidential outdoor use

X - EE - 

Materials preservativesIndoor use

1 For the six acute studies conducted with the end-use product, the test must be conducted using the product as formulated for sale and distribution. If the 

diluted for use, the applicant may also wish to conduct certain studies using the highest diluted concentration (i.e. lowest dilution rate) permitted by the la

2 If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, 

the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).

3 Required when the test substance contains an acid or base functionality (organic or inorganic) or an alcoholic functionality (organic).

4 Required if the TGAI or PAI is organic and non-polar.5 Required if the TGAI or PAI is organic and non-polar.6 If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, 

the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).

7 Required if the product is dispersible with water.8 If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, 

the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).

9 Data on the stability to metals and metal ions is required only if the active ingredient is expected to come in contact with either material during storage.

10 Required if the product contains an oxidizing or reducing agent11 Required when the product contains combustible liquids.12 Required when the product is potentially explosive.13 Required if the product is a liquid.14 Required if the product is an emulsifiable liquid and is to be diluted with petroleum solvents.15 If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, 

the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).
Case # and Name: 3026 Benzisothiazolin-3-one

DCI Number: PDCI-098901-27549

Footnotes: [The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Key:

United States Environmental Protection

Agency Washington, D.C. 20460

FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTS

TGAI & EP = Technical Grade of the Active Ingredient and End-Use Product; EP; MP; TGAI = End Use Product; Manufacturing Use Product; Technical Grade Technical Grade of the Active Ingredient or Pure Active Ingredient; EP = End Use Product [EP]; TGAI = Technical Grade Active Ingredient [TGAI]; EP; TGAI = Active Ingredient; EP & possibly TGAI = End- Use Product and possibly Technical Grade Active Ingredient

16 Required if the end-use product is a liquid and is to be used around electrical equipment.17 If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, 

the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).

18 If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, 

the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).

19 If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, 

the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).

20 Required when the TGAI is solid at room temperature.21 If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, 

the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).

22 Required if the TGAI is liquid at room temperature.23 If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, 

the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).

24 True density or specific density are required for all test substances. Data on bulk density is required for MPs that are solid at room temperature.

25 If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, 

the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).

26 If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, 

the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).

27 If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, 

the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).

28 Not required for salts.29 Data must be provided in accordance with the "Product Composition" Section.(158.155)30 Data must be provided in accordance with the "Description of Materials used to Produce the Product" Section.(158.160)
Case # and Name: 3026 Benzisothiazolin-3-one

DCI Number: PDCI-098901-27549

Footnotes: [The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Key:

United States Environmental Protection

Agency Washington, D.C. 20460

FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTS

TGAI & EP = Technical Grade of the Active Ingredient and End-Use Product; EP; MP; TGAI = End Use Product; Manufacturing Use Product; Technical Grade Technical Grade of the Active Ingredient or Pure Active Ingredient; EP = End Use Product [EP]; TGAI = Technical Grade Active Ingredient [TGAI]; EP; TGAI = Active Ingredient; EP & possibly TGAI = End- Use Product and possibly Technical Grade Active Ingredient

31 Data must be provided in accordance with the "Description of Production Process" Section.(158.162)32 Data must be provided in accordance with the "Description of Formulation Process" Section.(158.165)33 Data must be provided in accordance with the "Description of Formation of Impurities" Section(158.167)34 Data must be provided in accordance with the "Preliminary Analysis" Section.(158.170)35 Required for TGAIs and products produced by an integrated system.36 If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, 

the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).

37 Data must be provided in accordance with the "Certified Limits" Section(158.175)38 Data must be provided in accordance with the "Enforcement Analytical Method" Section.(158.180)39 Not required if test material is a gas or highly volatile.40 Not required if test material is corrosive to skin or has pH < 2 or >11.5; such a product will be classified as Toxicity Category I on the basis of potential de

41 Not required if test material is a gas or highly volatile.42 For the six acute studies conducted with the end-use product, the test must be conducted using the product as formulated for sale and distribution. If the 

diluted for use, the applicant may also wish to conduct certain studies using the highest diluted concentration (i.e. lowest dilution rate) permitted by the la

43 Not required if test material is corrosive to skin or has pH < 2 or > 11.5; such a product will be classified as Toxicity Category I on the basis of potential e

44 Required if intended use of the antimicrobial pesticide product will involve purposeful application on human skin or will result in comparable exposure to 

water), or if the active ingredient of the product is known or expected to be metabolized differently by the dermal route of exposure than by the oral routeis the toxic moiety. The EP shall also be tested if any component of the EP may increase dermal absorption of the active ingredient(s) or potentiate toxic 

45 For the six acute studies conducted with the end-use product, the test must be conducted using the product as formulated for sale and distribution. If the 

diluted for use, the applicant may also wish to conduct certain studies using the highest diluted concentration (i.e. lowest dilution rate) permitted by the la
Case # and Name: 3026 Benzisothiazolin-3-one

DCI Number: PDCI-098901-27549

Footnotes: [The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Key:

United States Environmental Protection

Agency Washington, D.C. 20460

FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTS

TGAI & EP = Technical Grade of the Active Ingredient and End-Use Product; EP; MP; TGAI = End Use Product; Manufacturing Use Product; Technical Grade Technical Grade of the Active Ingredient or Pure Active Ingredient; EP = End Use Product [EP]; TGAI = Technical Grade Active Ingredient [TGAI]; EP; TGAI = Active Ingredient; EP & possibly TGAI = End- Use Product and possibly Technical Grade Active Ingredient

46 Required if repeated dermal exposure is likely to occur under conditions of use.47 For the six acute studies conducted with the end-use product, the test must be conducted using the product as formulated for sale and distribution. If the 

diluted for use, the applicant may also wish to conduct certain studies using the highest diluted concentration (i.e. lowest dilution rate) permitted by the la

48 Required when the product consists of, or under conditions of use will result in, an inhalable material (e.g., gas, vapor, aerosol or particulates).

49 The 870 series studies for the MP and EP are intended to provide data on the acute toxicity of the product. Waivers for any or all of these studies may be 

demonstrate that the combination of inert ingredients is not likely to pose any significant human health risks. Where appropriate, the limit dose approach 

50 Required when the product consists of, or under conditions of use will result in, an inhalable material (e.g. gas, volatile substances, or aerosol particulate51 Not required if test material is a gas or highly volatile.52 For the six acute studies conducted with the end-use product, the test must be conducted using the product as formulated for sale and distribution. If the 

diluted for use, the applicant may also wish to conduct certain studies using the highest diluted concentration (i.e. lowest dilution rate) permitted by the la
United States Environmental Protection

Agency Washington, D.C. 20460

LIST OF ALL REGISTRANTS SENT THIS DATA CALL-IN NOTICE

Co. Nr. Company Name Agent For Address City & S

Case # and Name: 3026,Benzisothiazolin-3-one

TROY CHEMICAL COMPANYLIMITED

365 LEWIS & HARRISON 122 C ST NW STE 740 WASHIN5383 TROY CHEMICAL CORP PO Box 955 8 VREELAND ROAD FLORHA68575 TRUTEC INDUSTRIES INC 4700 GATEWAY BLVD SPRING

INTERNATIONAL SPECIALTYPRODUCTS

1529 1361 ALPS RD. WAYNE 39967 LANXESS CORPORATION 111 RIDC PARK WEST DRIVE PITTSB464 DOW CHEMICAL CO., THE THE DOW CHEMICAL COMPANY 1500 EAST LAKE COOK ROAD BUFFAL6836 LONZA INC 90 BOROLINE ROAD ALLEND80285 PROMCHEMIE AG MCDERMOTT, WILL & EMERY LLP 600 13TH STREET, NW WASHIN1258 ARCH CHEMICALS, INC. 5660 NEW NORTHSIDE DRIVE, N.W., SUITE 1100 ATLANT49403 CLARIANT CORPORATION LEWIS & HARRISON 122 C ST NW STE 740 WASHIN

MAKHTESHIM-AGAN OF NORTHAMERICA INC

66222 4515 FALLS OF NEUSE RD, SUITE 300 RALEIG3090 SANITIZED INC PO Box 2211 57 NEW MILFORD TKPE. NEW PR707 ROHM & HAAS CO 100 INDEPENDENCE MALL WEST PHILAD53883 CONTROL SOLUTIONS, INC. D. O'SHAUGHNESSY CONSULTING, INC. 427 HIDE AWAY CIRCLE CUB RU67071 THOR GMBH THOR SPECIALTIES INC. 56 QUARRY ROAD TRUMB